GNMK Share Price

Open 12.61 Change Price %
High 12.61 1 Day -0.35 -2.78
Low 12.22 1 Week -0.15 -1.21
Close 12.24 1 Month -0.90 -6.85
Volume 220672 1 Year 3.96 47.83
52 Week High 13.67
52 Week Low 8.03
GNMK Important Levels
Resistance 2 12.60
Resistance 1 12.45
Pivot 12.36
Support 1 12.03
Support 2 11.88
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
DCTH 0.22 0.00%
FNFG 10.18 -0.20%
ASTI 0.00 0.00%
DELL 13.86 0.22%
QQQ 138.03 -1.81%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SMSI 1.62 24.62%
CGEI 0.22 22.22%
THTI 0.20 17.65%
MYRX 0.07 16.67%
BDMS 13.50 16.38%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
More..

GenMark Diagnostics, Inc. (NASDAQ: GNMK)

GNMK Technical Analysis 1.5
As on 27th Jun 2017 GNMK Share Price closed @ 12.24 and we RECOMMEND Buy for LONG-TERM with Stoploss of 11.70 & Sell for SHORT-TERM with Stoploss of 12.80 we also expect STOCK to react on Following IMPORTANT LEVELS.
GNMK Target for June
1st Target up-side 13.74
2nd Target up-side 14.29
3rd Target up-side 14.85
1st Target down-side 12.14
2nd Target down-side 11.59
3rd Target down-side 11.03
GNMK Other Details
Segment EQ
Market Capital 273291424.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.genmarkdx.com
GNMK Address
GNMK
5964 La Place Court
Carlsbad, CA 92008
United States
Phone: 760-448-4300
Fax: 760-448-4301
GNMK Latest News
Interactive Technical Analysis Chart GenMark Diagnostics, Inc. ( GNMK NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on GenMark Diagnostics, Inc.
GNMK Business Profile
GenMark Diagnostics, Inc. (GenMark) is a molecular diagnostics company focused on developing and commercializing its eSensor detection technology. The Company�s electrochemical technology enables detection of up to 72 distinct biomarkers in a single sample. Its XT-8 System has received 510(k) clearance from the United States Food and Drug Administration (FDA), and is designed to support a range of molecular diagnostic tests with a compact workstation and self-contained, disposable test cartridges. Within 30 minutes of receipt of an amplified deoxyribonucleic acid (DNA) sample, its XT-8 System produces results. The XT-8 System supports up to 24 test cartridges, which can be run independently, and are targeted for hospitals and reference laboratories. The Company is also developing its next-generation platform, the AD-8 System, to integrate DNA amplification with its eSensor detection technology to enable technicians to place a minimally prepared patient sample into its test cartridge.